Shares of Apogee Therapeutics, Inc. (APGE) gained over 14% on Wednesday morning after the company priced an equity offering of 5 million shares at $70 a share.
The stock is currently trading at $82.98, up $9.98 or 13.67%, on the Nasdaq. It opened at $74.53 after closing the previous session at $73.00. The stock has traded between $26.20 and $85.04 over the past 52 weeks.
Apogee Therapeutics announced the pricing of its underwritten public offering of 5.0 million shares at $70.00 per share, raising approximately $350 million in gross proceeds.
The offering is expected to close on March 26, 2026, subject to customary closing conditions.
Proceeds from the offering are expected to support the company's pipeline of biologics targeting inflammatory and immunology markets, as it advances clinical development programs.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.